薬物乱用検査の世界市場:産業分析および機会分析

◆英語タイトル:Drug of Abuse Testing Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
◆商品コード:FMI20JA090
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2019年10月11日
◆ページ数:185
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査は薬物乱用検査について、エグゼクティブサマリー、市場概要、市場背景、需要分析、薬物タイプ別(精神刺激薬、麻薬、カンナビノイド、鎮静剤、その他)分析、テクニック別(イムノアッセイ、クロマトグラフィー、迅速な試験)分析、エンドユーザー別(病院、診断研究所、法医学研究所、その他)分析、地域別分析、競合分析、調査手法に区分して掲載しています。
・エグゼクティブサマリー
・市場概要
・市場背景
・需要分析
・薬物乱用検査の世界市場:薬物タイプ別(精神刺激薬、麻薬、カンナビノイド、鎮静剤、その他)
・薬物乱用検査の世界市場:テクニック別(イムノアッセイ、クロマトグラフィー、迅速な試験)
・薬物乱用検査の世界市場:エンドユーザー別(病院、診断研究所、法医学研究所、その他)
・薬物乱用検査の世界市場:地域別
・競合分析
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights on the drug of abuse testing market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the drug of abuse testing market, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the drug of abuse testing market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the drug of abuse testing market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the drug of abuse testing market in this chapter, which will help them understand the basic information about the drug of abuse testing market. Along with this, comprehensive information pertaining to drug of abuse testing and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the drug of abuse testing market report.

Chapter 03 – Market Dynamics

This section gives information about drivers, and restraints of the drug of abuse testing market. This section also includes various opportunities and key trends of the drug of abuse testing market.

Chapter 04 – Market Context

This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the drug of abuse testing market.

Chapter 05 – Global Drug of Abuse Testing Market Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the drug of abuse testing market between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical drug of abuse testing market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Drug Type

Based on drug type, the drug of abuse testing market is segmented into psychostimulants, narcotic, cannabinoids, sedatives and others. In this chapter, readers can find information about the key trends and developments in the drug of abuse testing market and market attractiveness analysis based on the type.

Chapter 07 – Global Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Technique

Based on technique, the drug of abuse testing market is segmented into immunoassay, chromatography and rapid testing. In this chapter, readers can understand the market attractive analysis based on technique.

Chapter 08 – Global Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by End User

This chapter provides details about the drug of abuse testing market based on the end user, and has been classified into hospitals, diagnostics laboratories, forensic laboratories and others. In this chapter, readers can understand the market attractive analysis based on the end user.

Chapter 08 – Global Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the drug of abuse testing market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 09 – North America Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America drug of abuse testing market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the drug type, technique, end user, and countries in North America.

Chapter 10 – Latin America Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the drug of abuse testing market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 11 – Western Europe Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the drug of abuse testing market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Nordics and the Rest of Western Europe are included in this chapter.

Chapter 11 – Eastern Europe Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the drug of abuse testing market based on its end users in several countries such as Russia, Poland and the Rest of Eastern Europe are included in this chapter.

Chapter 12 – Asia Pacific excluding Japan (APEJ) Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

In this chapter, China, India, Australia and New Zealand, ASEAN and Rest of Asia Pacific countries are the prominent countries in the Asia Pacific excluding Japan region that are the prime subjects of assessment to obtain the growth prospects of the APEJ drug of abuse testing market. Readers can find detailed information about the growth parameters of the APEJ drug of abuse testing market during the forecast period of 2019-2029.

Chapter 13 – Japan Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section highlights the growth prospects of the drug of abuse testing market for Japan, during the forecast period of 2019-2029

Chapter 14 – MEA Drug of Abuse Testing Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the drug of abuse testing market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 15 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the drug of abuse testing market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Quest Diagnostics, Roche Holding AG, Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Abbott Laboratories (Alere, Inc.), Shimadzu Corporation, Express Diagnostics International Inc., Drägerwerk AG & Co. KGaA, and Laboratory Corporation of America Holdings.

Chapter 16 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the drug of abuse testing market report.

Chapter 17 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the drug of abuse testing market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Growing Impact of Drug and Alcohol Abuse on Public Health

3.1.2. Rise in Law Enforcement Spending for Illicit Drug Interdiction

3.2. Forecast Factors – Relevance & Impact

3.2.1. Rise in Number of Clinical Laboratories offering Drugs of Abuse Testing Services

3.2.2. Awareness Initiatives from the Manufacturers

3.2.3. Rising R&D investments

3.2.4. Drug Abuse Testing Regulation

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunity Analysis

4. Global Drug of Abuse Testing Market Demand (Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Type

5.1. Introduction / Key Findings

5.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014–2018

5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019-2029

5.3.1. Psychostimulants

5.3.2. Narcotics

5.3.3. Cannabinoids

5.3.4. Sedatives

5.3.5. Others

5.4. Market Attractiveness Analysis By Drug Type

6. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by Technique

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Technique, 2014–2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2019-2029

6.3.1. Immunoassay

6.3.2. Chromatography

6.3.3. Rapid Testing

6.4. Market Attractiveness Analysis By Technique

7. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by End User

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By End User, 2014–2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2029

7.3.1. Hospitals

7.3.2. Diagnostics Laboratories

7.3.3. Forensic Laboratories

7.3.4. Others

7.4. Market Attractiveness Analysis By End User

8. Global Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029, by Region

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014–2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. APEJ

8.3.6. Japan

8.3.7. MEA

8.4. Market Attractiveness Analysis By Region

9. North America Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

9.3.1. By Country

9.3.1.1. U.S.

9.3.1.2. Canada

9.3.2. By Drug Type

9.3.3. By Technique

9.3.4. By End User

9.4. Market Attractiveness Analysis

9.4.1. By Country

9.4.2. By Drug Type

9.4.3. By Technique

9.4.4. By End User

9.5. Key Market Participants – Intensity Mapping

9.6. Drivers and Restraints – Impact Analysis

10. Latin America Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

10.3.1. By Country

10.3.1.1. Brazil

10.3.1.2. Mexico

10.3.1.3. Rest of Latin America

10.3.2. By Drug Type

10.3.3. By Technique

10.3.4. By End User

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Drug Type

10.4.3. By Technique

10.4.4. By End User

10.5. Key Market Participants – Intensity Mapping

10.6. Drivers and Restraints – Impact Analysis

11. Western Europe Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. Germany

11.3.1.2. UK

11.3.1.3. France

11.3.1.4. Spain

11.3.1.5. Italy

11.3.1.6. Nordic Countries

11.3.1.7. Rest of WE

11.3.2. By Drug Type

11.3.3. By Technique

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Drug Type

11.4.3. By Technique

11.4.4. By End User

11.5. Key Market Participants – Intensity Mapping

11.6. Drivers and Restraints – Impact Analysis

12. Eastern Europe Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. Russia

12.3.1.2. Poland

12.3.1.3. Rest of EE

12.3.2. By Drug Type

12.3.3. By Technique

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Drug Type

12.4.3. By Technique

12.4.4. By End User

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. APEJ Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia & NZ

13.3.1.4. ASEAN

13.3.1.5. Rest of APEJ

13.3.2. By Drug Type

13.3.3. By Technique

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Drug Type

13.4.3. By Technique

13.4.4. By End User

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Japan Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. Japan

14.3.2. By Drug Type

14.3.3. By Technique

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Drug Type

14.4.3. By Technique

14.4.4. By End User

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. Middle East and Africa Drug of Abuse Testing Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

15.3.1. By Country

15.3.1.1. GCC Countries

15.3.1.2. South Africa

15.3.1.3. Rest of MEA

15.3.2. By Drug Type

15.3.3. By Technique

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Drug Type

15.4.3. By Technique

15.4.4. By End User

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Competition Deep Dive (Tentative List)

16.3.1. Quest Diagnostics

16.3.1.1. Overview

16.3.1.2. Service Portfolio

16.3.1.3. Profitability by Market Segments (Service/Channel/Region)

16.3.1.4. Sales Footprint

16.3.1.5. Strategy Overview

16.3.1.5.1. Marketing Strategy

16.3.1.5.2. Service Strategy

16.3.1.5.3. Channel Strategy

16.3.2. F. Hoffmann-La Roche Ltd

16.3.2.1. Overview

16.3.2.2. Service Portfolio

16.3.2.3. Profitability by Market Segments (Service/Channel/Region)

16.3.2.4. Sales Footprint

16.3.2.5. Strategy Overview

16.3.2.5.1. Marketing Strategy

16.3.2.5.2. Service Strategy

16.3.2.5.3. Channel Strategy

16.3.3. Siemens AG (Siemens Healthineers)

16.3.3.1. Overview

16.3.3.2. Service Portfolio

16.3.3.3. Profitability by Market Segments (Service/Channel/Region)

16.3.3.4. Sales Footprint

16.3.3.5. Strategy Overview

16.3.3.5.1. Marketing Strategy

16.3.3.5.2. Service Strategy

16.3.3.5.3. Channel Strategy

16.3.4. Thermo Fisher Scientific, Inc.

16.3.4.1. Overview

16.3.4.2. Service Portfolio

16.3.4.3. Profitability by Market Segments (Service/Channel/Region)

16.3.4.4. Sales Footprint

16.3.4.5. Strategy Overview

16.3.4.5.1. Marketing Strategy

16.3.4.5.2. Service Strategy

16.3.4.5.3. Channel Strategy

16.3.5. Abbott Laboratories (Alere, Inc.)

16.3.5.1. Overview

16.3.5.2. Service Portfolio

16.3.5.3. Profitability by Market Segments (Service/Channel/Region)

16.3.5.4. Sales Footprint

16.3.5.5. Strategy Overview

16.3.5.5.1. Marketing Strategy

16.3.5.5.2. Service Strategy

16.3.5.5.3. Channel Strategy

16.3.6. Shimadzu Corporation

16.3.6.1. Overview

16.3.6.2. Service Portfolio

16.3.6.3. Profitability by Market Segments (Service/Channel/Region)

16.3.6.4. Sales Footprint

16.3.6.5. Strategy Overview

16.3.6.5.1. Marketing Strategy

16.3.6.5.2. Service Strategy

16.3.6.5.3. Channel Strategy

16.3.7. Laboratory Corporation of America Holdings

16.3.7.1. Overview

16.3.7.2. Service Portfolio

16.3.7.3. Profitability by Market Segments (Service/Channel/Region)

16.3.7.4. Sales Footprint

16.3.7.5. Strategy Overview

16.3.7.5.1. Marketing Strategy

16.3.7.5.2. Service Strategy

16.3.7.5.3. Channel Strategy

16.3.8. Drägerwerk AG & Co. KGaA

16.3.8.1. Overview

16.3.8.2. Service Portfolio

16.3.8.3. Profitability by Market Segments (Service/Channel/Region)

16.3.8.4. Sales Footprint

16.3.8.5. Strategy Overview

16.3.8.5.1. Marketing Strategy

16.3.8.5.2. Service Strategy

16.3.8.5.3. Channel Strategy

16.3.9. Express Diagnostics International Inc.

16.3.9.1. Overview

16.3.9.2. Service Portfolio

16.3.9.3. Profitability by Market Segments (Service/Channel/Region)

16.3.9.4. Sales Footprint

16.3.9.5. Strategy Overview

16.3.9.5.1. Marketing Strategy

16.3.9.5.2. Service Strategy

16.3.9.5.3. Channel Strategy

17. Assumptions and Acronyms Used

18. Research Methodology



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[薬物乱用検査の世界市場:産業分析および機会分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆